BioCentury
ARTICLE | Clinical News

Hemoglobin glutamer: IND resubmitted

March 30, 2009 7:00 AM UTC

The Naval Medical Research Center (NMRC) submitted a revised protocol to FDA for the Phase IIb/III RESUS trial designed to enroll injured civilians in the U.S. In 2006, an FDA committee recommended a...